Skip to content

High dose

DIETARY_SUPPLEMENT18 trials

Sponsors

The First Affiliated Hospital of Anhui Medical University, Shulan (Hangzhou) Hospital, University of Missouri-Columbia, University of Calgary, University of Toronto

Conditions

Acute Myocardial InfarctionBioavailabilityChronic Spinal Cord InjuryChronic hepatitis BColitis, UlcerativeFood AllergyGraves' DiseaseHIV Infections

Early Phase 1

Phase 1

Phase 2

Unknown Phase

Fathers and Late Preterm Babies Study
CompletedNCT01056653
University of CalgaryPremature Birth
Start: 2008-12-31End: 2013-01-31Updated: 2017-03-29
Vitamin D Fortified Cheese and Well-being in the Institutionalized Elderly
NCT01555424
University of TorontoThe Focus is to Assess 25-hydroxyvitamin D Levels and Well-being
Start: 2012-02-29End: 2012-04-30Updated: 2012-03-15
Comparative Study of Different I-131 Doses in Graves' Disease
NCT02114619
Mashhad University of Medical SciencesGraves' Disease
Start: 2013-05-31End: 2016-12-31Target: 450Updated: 2014-04-15
Reducing Anticholinergic Bladder Medication Use in Spinal Cord Injury With Home Neuromodulation
CompletedNCT04074616
The University of Texas Health Science Center, HoustonChronic Spinal Cord Injury, Neurogenic Bladder
Start: 2019-11-19End: 2023-04-20Updated: 2024-10-15
High and Low Dose Oral Sesame Immunotherapy - Comparison of Efficacy and Safety
RecruitingNCT05158413
Medical University of WarsawFood Allergy
Start: 2022-03-31End: 2025-06-30Target: 40Updated: 2024-03-20
Food Supplement Effect on Overweight or Moderate Obesity
CompletedNCT05178667
Institut Pasteur de LilleObesity
Start: 2022-01-06End: 2022-10-31Updated: 2022-12-16
Factorial Trial Testing Guided Thinking Tasks to Optimize a Physical Activity Intervention
NCT05235360
Southern Methodist UniversityPhysical Inactivity
Start: 2022-02-14End: 2023-07-31Target: 192Updated: 2022-02-28
Blood Bioavailability of Two Different Doses of a β-alanine Supplement (BIo-β)
CompletedNCT06214338
Universidad Católica San Antonio de MurciaBioavailability
Start: 2024-02-12End: 2024-04-15Updated: 2024-05-20
ABG+/GarlACE Effects on Cardiovascular Risk Factors in Subjects With Grade I Hypertension
RecruitingNCT06264622
Universitat de LleidaHypertension
Start: 2024-02-26End: 2024-12-31Target: 180Updated: 2024-02-20

Related Papers